Related Experiment Videos
Cefmetazole versus cefoxitin in prevention of infections after abdominal surgery
1Department of Internal Medicine, Ohio State University Hospitals, Columbus 43210.
The Journal of Antimicrobial Chemotherapy
|April 1, 1989
Abstract:
Patients undergoing elective abdominal surgery were randomized to receive cefmetazole or cefoxitin in a three-dose perioperative prophylactic regimen. There were three infections in 89 evaluable patients receiving cefmetazole. There were six infections in 39 patients receiving cefoxitin. Both regimens were acceptable with minimal toxicity.
Insights
Cefmetazole and cefoxitin are effective prophylactic antibiotics for abdominal surgery patients. Both antibiotic regimens demonstrated acceptable safety profiles with minimal toxicity in this comparative study.
Area of Science:
- Infectious Diseases
- Surgical Prophylaxis
- Pharmacology
Background:
- Surgical site infections (SSIs) are a significant concern in abdominal surgery.
- Perioperative antibiotic prophylaxis is crucial for preventing SSIs.
- Choosing the optimal prophylactic agent is essential for patient outcomes.
Purpose of the Study:
- To compare the efficacy and safety of cefmetazole versus cefoxitin for perioperative antibiotic prophylaxis in elective abdominal surgery.
- To evaluate the rate of surgical site infections and toxicity associated with each antibiotic regimen.
Main Methods:
- A randomized controlled trial was conducted.
- Patients received a three-dose perioperative prophylactic regimen of either cefmetazole or cefoxitin.
- Infection rates and adverse events were monitored and compared between the two groups.
Main Results:
- Three infections occurred in 89 patients who received cefmetazole.
- Six infections occurred in 39 patients who received cefoxitin.
- Both cefmetazole and cefoxitin regimens were well-tolerated with minimal observed toxicity.
Conclusions:
- Cefmetazole and cefoxitin are both effective prophylactic antibiotics for elective abdominal surgery.
- The observed infection rates suggest comparable efficacy between the two agents.
- Both regimens offer acceptable safety profiles, making them suitable choices for surgical prophylaxis.